CREATES Act of 2017

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

R MarinoSponsor

25 cosponsors · 13 D, 12 R

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017

What it does: CRS summary · Introduced in House · Apr 27, 2017

Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017

This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: CREATES Act of 2017

Also known as: Creating and Restoring Equal Access To Equivalent Samples Act of 2017

Latest action (Apr 28, 2017): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Apr 27, 2017

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.